On December 9, 2020 Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing three novel cell therapies for serious medical conditions, reported that Brian M. Culley, Chief Executive Officer, will be presenting at the 13th Annual LD Micro Main Event virtual conference on December 14, 2020 at 12:00 pm Eastern Time / 9:00am Pacific Time (Press release, Lineage Cell Therapeutics, DEC 9, 2020, View Source [SID1234572508]). Interested investors can register and access the live presentation on the 13th Annual LD Micro Main Event conference page as well as on the Events and Presentations section of Lineage’s website.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The archived presentation will be available on the Events and Presentations section of Lineage’s website for 30 days. Additional videos are available on the Media page of the Lineage website, located at www.lineagecell.com/media/.